Juhua Co. 2024 Net Profit Expected to Increase by 98%-123%
On January 23, Juhua Co. announced a significant performance increase for 2024, projecting a net profit attributable to shareholders of between 1.87 billion to 2.1 billion yuan, reflecting a remarkable year-on-year increase of 98% to 123%. The company also expects its net profit, excluding non-recurring gains and losses, to reach between 1.721 billion to 1.951 billion yuan, marking an increase of 109% to 137% compared to the previous year.
In 2024, Juhua's production of refrigerants is anticipated to reach 591,405 tons, a 21.12% increase, with revenue expected to reach 944.7 million yuan, up 62.69%. Meanwhile, fluoropolymer materials production is projected at 131,846 tons, showing a modest 2.92% increase, but revenue is expected to decrease by 10.92% to 183.9 million yuan. The company forecasts a remarkable 148.99% increase in the production of fluorinated fine chemicals, with revenues soaring by 99.48% to 27.8 million yuan.
The primary drivers behind Juhua's impressive growth include increased external sales and rising prices for its major products. The company highlighted several factors contributing to this financial success:
Market Dynamics: Juhua's second and third-generation fluorinated refrigerants have seen improved supply-demand dynamics and competitive order under production quotas, leading to a substantial price recovery in these products.
Business Structure: With the rebound in refrigerant prices, the segment's contribution to Juhua's overall business structure and profitability has significantly increased. The positive impact of rising refrigerant prices has outweighed the negative effects from declining prices in non-refrigerant chemical products.
As Juhua continues to capitalize on these trends, its market position is expected to strengthen, further enhancing its profitability in the upcoming year.
2026-08-10
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
From Painting Walls to Total Collapse: The RMB 152 Million Debt That Tore Off the Last Veil of Asia Chuangneng’s Paint Empire
-
“Amputation or Strategic Retreat?”: Shell’s Six-Year Chemical Losses and the Quiet Unwinding of an Empire
-
Wegovy Slips on Price While Mounjaro Defends Its Weight-Loss Crown
-
A New Obesity Pill Enters the Arena With Double-Digit Weight Loss
-
Lilly’s Mounjaro Enters China’s State Insurance System
-
Vertex Pushes Gene Therapy Into Younger Children With Blood Disorders
-
Selling the Family Silver for a New Suit? Why Bohai Chemical’s Transformation Drama Got Canceled After Just Two Acts
-
Smog Becomes a Sales Catalyst as Respiratory Drugs Surge in November
-
Arkema and ENNEX Forge Global Alliance to Power the Next Generation of Safer, Smarter Battery Separators
-
Sherwin-Williams Opens High-Performance Industrial Coatings Facility in Saskatchewan
Recommend Reading
-
India Targets Fake Drug Packaging
-
India’s Pharma Cost Problem Gets Worse
-
Global Chemical Giants Light the Fuse: A TDI/MDI Price Storm Sweeps Asia and Europe—Who’s Fueling This “Cost Carnival”?
-
Probiotics Push for Economic Value
-
Plant Omega-3 Gets a New Argument
-
FDA Warning Letters Put GMP Back in Focus
-
FDA Fast-Tracks U.S. Drug Manufacturing
-
Magnesium Chloride (MgCl₂): Properties, Uses, and Applications
-
Supply Reduction Leads to Rapid Increase in n-Butanol Market
-
Flavin Adenine Dinucleotide (FAD): Functions and Applications